
    
      This study seeks to define the role of gallium nitrate in a specific population of patients
      who are expected to have received prior therapy. Preliminary clinical studies have suggested
      substantial evidence of antitumor activity in patients with relapsed or refractory
      non-Hodgkin's Lymphoma treated with gallium nitrate.
    
  